FlexCare Infusion Center
FlexCare Infusion Centers operates 40+ outpatient infusion clinics across six U.S. states, providing IV and injection therapies for patients with chronic and complex conditions. A subsidiary of Optum/UnitedHealth Group, it supplements clinic services with home infusion and a web-based provider portal.
- Company typePrivate
- Founded2022
- HeadquartersOklahoma City, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What FlexCare Infusion Center does
FlexCare Infusion Centers is a U.S. outpatient infusion therapy operator founded in 2019 and headquartered in Oklahoma City, operating 40+ clinic sites across six states: Alabama, Arizona, Colorado, Oklahoma, Washington, and West Virginia. The company delivers FDA-approved injection and intravenous infusion therapies for patients with chronic, complex, and rare conditions spanning rheumatology, neurology, gastroenterology, dermatology, immunology, pulmonology, endocrinology, oculoplastics, allergy, and kidney disease. Each clinic operates in private or semi-private infusion suites with amenities such as recliners, Wi-Fi, and streaming, and offers extended hours including evenings and weekends; a FlexCare Home Infusion service extends the model to eligible patients in their residences. The technical stack centers on a web-based Provider Portal (flexcareportal.com) that allows referring physicians to submit referrals, upload pharmacy orders, and track referral, treatment, and prescription status in real time via an in-portal chat channel.
FlexCare generates revenue by billing payers (Medicare, Medicaid, and commercial insurance) for outpatient infusion and injection services; pricing is driven by patient insurance coverage rather than a published fee schedule, and the company advertises lower out-of-pocket costs than hospital settings for many plans. Its go-to-market is provider-referral driven, supported by referral forms, a fax/email intake process, and the Provider Portal, with internal staff handling prior authorization, insurance verification, denial appeals, and letters of medical necessity to remove administrative friction. FlexCare holds ACHC Gold Seal Accreditation, an asset relevant to payor contracting and home health service quality.
In January 2022 FlexCare acquired InfuseAble Care to enter Arizona and added BioCure Rx later that year; the company was acquired by Optum (UnitedHealth Group) in 2025, becoming a wholly-owned subsidiary. The company has a partnership with Mandolin's AI platform to automate specialty-drug prior authorization, reporting compression of time-to-treatment from weeks to days across a base serving approximately 250,000 new patients annually. Co-founders Aaron Smith (CEO) and Callie Turk (COO) led the company through the pre-Optum growth phase.
FlexCare Infusion Center firmographics
Firmographics- Name
- FlexCare Infusion Center
- Legal name
- FlexCare Infusion Centers
- Website
- https://flexcareinfusion.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- FlexCare Infusion Centers operates 40+ outpatient infusion clinics across six U.S. states, providing IV and injection therapies for patients with chronic and complex conditions. A subsidiary of Optum/UnitedHealth Group, it supplements clinic services with home infusion and a web-based provider portal.
- Ownership category
- akta.pro rank
FlexCare Infusion Center industry classification
Industry- Product category
- Outpatient Infusion Therapy Services
- NAICS
- All Other Outpatient Care Centers (621498), Home Health Care Services (62161), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Infusion Therapy Centers (Outpatient) (HLAFABAF)
- akta.pro secondary industries
- Infusion & Home Infusion Pharmacy Services (HLAFALAG), Home Infusion Therapy Providers (HLAFAEAE), IV Therapy, Infusion & Injection Services (Home-Based) (HSABACAF)
Keywords
Where FlexCare Infusion Center is headquartered
LocationHeadquarters
- HQ city
- Oklahoma City
- HQ country
- United States
- HQ region
- North America
Offices40 records
Markets served
FlexCare Infusion Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Infusion Therapy Services: FlexCare generates revenue by providing outpatient infusion and injection therapy services to patients with chronic and complex conditions. Services are billed through insurance, with reimbursement determined by patients' insurance coverage including Medicare, Medicaid, and commercial plans.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
FlexCare Infusion Center product offering
Product offeringCore offering
FlexCare Infusion Center operates a network of outpatient infusion and injection therapy clinics across six U.S. states (Alabama, Arizona, Colorado, Oklahoma, Washington, and West Virginia), providing FDA-approved medications for patients with rare, chronic, and complex conditions including rheumatic, neurological, gastrointestinal, kidney, dermatological, endocrine/oculoplastic, and allergy/immunology/pulmonology conditions. The company also offers home infusion services and a web-based Provider Portal that enables physicians to submit referrals, track treatment status, and manage prior authorizations and insurance verification.
Product overview
FlexCare Infusion Centers operates a network of outpatient infusion therapy clinics across six U.S. states (Alabama, Arizona, Colorado, Oklahoma, Washington, West Virginia). The core offering is infusion and injection therapy for chronic and complex conditions, supplemented by a Provider Portal for referral management and real-time status tracking, and a Home Infusion service for in-home treatment. The company manages the full care pathway from referral through treatment administration, including prior authorization and insurance verification services.
Differentiator
Problem solved
Functional benefit
Products and services
- Outpatient Infusion and Injection Therapy Outpatient infusion and injection therapy services providing FDA-approved medications for chronic and complex conditions including rheumatic, neurological, gastrointestinal, kidney, dermatological, endocrine/oculoplastic, and allergy/immunology/pulmonology conditions. Delivered in private or semi-private infusion suites across clinics in six U.S. states.
- Provider Portal Secure web portal enabling healthcare providers to upload patient referrals and pharmacy orders, track referral, treatment, and prescription statuses in real-time, and communicate directly with the FlexCare care team via chat.
- FlexCare Home Infusion In-home infusion therapy treatment for patients with rare, chronic, and complex conditions, allowing patients to receive treatment from the comfort of their home rather than at a clinic.
- Referral Management and Prior Authorization Services Administrative service handling prior authorizations, insurance verification, denial appeals, and letters of medical necessity to streamline patient referrals from physicians.
Quantifiable outcome
- Contact patients within 1-2 business days after receiving referral
- +2 more outcomes
Companies that use FlexCare Infusion Center
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
FlexCare Infusion Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
FlexCare Infusion Center partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Optum (UnitedHealth Group)coreFlexCare Infusion was acquired by Optum, a subsidiary of UnitedHealth Group. This acquisition positions FlexCare as part of a major healthcare services organization, providing integration with Optum's broader healthcare network and resources.
- Mandolin AI PlatformcoreFlexCare is a major infusion provider partner for Mandolin's AI automation platform, which helps automate administrative processes for specialty drug access. The partnership enables FlexCare to reduce time-to-treatment from weeks to days and cut back-office costs while serving approximately 250,000 new patients annually.
- InfuseAble CarecoreFlexCare acquired InfuseAble Care in January 2022, expanding its operations into Arizona and growing to 11 clinics across three states at that time. The acquisition aimed to enhance access to specialized infusion treatments for patients with complex conditions.
Scale indicators4 records
Recent moves6 records
Expansion highlights3 records
FlexCare Infusion Center competitors and assessment
Company assessmentEmerging players
- Strive Health: Value-based kidney care provider offering in-clinic and home infusion services for ESRD/CKD patients. Partial overlap with FlexCare's nephrology treatment capabilities and outpatient infusion model.
- Innovista Health: Provider services and care management platform with infusion-related offerings for complex patient populations. Adjacent comparator in the chronic/complex outpatient care delivery space.
- Local Infusion: Multi-state outpatient infusion operator focused on autoimmune and specialty conditions with concierge-style clinics. Direct niche competitor with overlapping therapy mix and patient experience positioning.
Broad incumbents
- Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S. While broader and primarily home-infusion focused, it overlaps with FlexCare's Home Infusion arm and competes for the same specialty drug referrals.
- Coram (CVS Health): CVS Health's home and alternate-site infusion subsidiary serving complex chronic conditions. Competes with FlexCare's Home Infusion offering and benefits from CVS Caremark payer integration.
- Accredo (Cigna/Express Scripts): Specialty pharmacy and home infusion arm of Cigna. Competes with FlexCare for specialty therapy referrals and benefits from integrated payer-provider economics.
- Amerita (PharMerica): Specialty infusion provider serving acute and chronic conditions in home and alternate-site settings. Adjacent competitor for chronic infusion referrals, particularly for higher-acuity therapies.
Direct peers
- IVX Health: National outpatient infusion therapy platform operating private suites for chronic conditions like autoimmune and rheumatologic disease. Most direct competitor to FlexCare in the patient-experience-focused infusion clinic category.
- BioMatrix Specialty Pharmacy: Specialty pharmacy and infusion provider focused on chronic and complex conditions including immune globulin and biologic infusions. Overlaps with FlexCare on therapy mix and provider-referral acquisition model.
- Vital Care Infusion Services: Franchise-style network of ambulatory infusion centers across multiple U.S. states serving patients with chronic and complex conditions. Closely comparable multi-state outpatient infusion model with similar referral-based GTM.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FlexCare Infusion Center social profiles
Digital presenceFlexCare Infusion Center compliance and trust
Trust signalCompliance1 record
FlexCare Infusion Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
FlexCare Infusion Center leadership team
Management profileNumber of profiles
Profiles2 records
FlexCare Infusion Center subsidiaries and ownership
Company hierarchySubsidiaries1 record
FlexCare Infusion Center funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FlexCare Infusion Center M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FlexCare Infusion Center
What does FlexCare Infusion Center do?
FlexCare Infusion Center operates a network of outpatient infusion and injection therapy clinics across six U.S. states (Alabama, Arizona, Colorado, Oklahoma, Washington, and West Virginia), providing FDA-approved medications for patients with rare, chronic, and complex conditions including rheumatic, neurological, gastrointestinal, kidney, dermatological, endocrine/oculoplastic, and allergy/immunology/pulmonology conditions. The company also offers home infusion services and a web-based Provider Portal that enables physicians to submit referrals, track treatment status, and manage prior authorizations and insurance verification.
Is FlexCare Infusion Center a public or private company?
FlexCare Infusion Center is a private company. It is classified as corporate owned and is currently operating.
When was FlexCare Infusion Center founded?
FlexCare Infusion Center was founded in 2022. It employs 1 to 10 people.
Where is FlexCare Infusion Center based?
FlexCare Infusion Center is headquartered in Oklahoma City, United States, in the North America region.
How does FlexCare Infusion Center make money?
One revenue line is on record: infusion Therapy Services.
Who are FlexCare Infusion Center's main competitors?
Emerging players on record are Strive Health, Innovista Health and Local Infusion. Broad incumbents are Option Care Health, Coram (CVS Health), Accredo (Cigna/Express Scripts) and Amerita (PharMerica). Direct peers are IVX Health, BioMatrix Specialty Pharmacy and Vital Care Infusion Services.
Does FlexCare Infusion Center have an API?
No public API is recorded for FlexCare Infusion Center.
What industry is FlexCare Infusion Center in?
FlexCare Infusion Center's product category is Outpatient Infusion Therapy Services. Its primary akta.pro industry code is HLAFABAF, Infusion Therapy Centers (Outpatient), with a secondary code of HLAFALAG, Infusion & Home Infusion Pharmacy Services. Its NAICS code is 621498 and its SIC code is 8093.